Renhe Pharmacy Co.,Ltd (SHE:000650)
China · Delayed Price · Currency is CNY 4.890
-0.059 (-1.20%)
Nov 13, 2026, 3:04 PM CST
Renhe Pharmacy Co.,Ltd Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,495 | 3,536 | 4,075 | 5,032 | 5,153 | 4,936 |
Revenue Growth | -7.00% | -13.21% | -19.02% | -2.35% | 4.41% | 15.38% |
Gross Profit Gross Profit Growth | 1,280 | 1,294 | 1,533 | 1,845 | 1,845 | 1,865 |
Operating Income Operating Income Growth | 543.86 | 584.79 | 671.27 | 943.83 | 878.95 | 922.49 |
Net Income Net Income Growth | 386.24 | 393.21 | 481.91 | 567.26 | 574.43 | 665.02 |
Earnings Per Share EPS Growth | 0.28 | 0.28 | 0.35 | 0.41 | 0.41 | 0.48 |
EPS Growth | -13.84% | -18.93% | -14.76% | -1.17% | -14.58% | 4.35% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Medicine (including health products) Medicine (including health products) Growth | 3,409 | 3,451 | 3,995 | 4,927 | 5,075 | 4,841 |
Unallocated Others Unallocated Others Growth | - | 85.52 | 79.63 | 105.17 | 78.56 | 94.45 |
Total Total Growth | 3,495 | 3,536 | 4,075 | 5,032 | 5,153 | 4,936 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 4,136 | 4,006 | 3,731 | 3,534 | 3,532 | 2,776 |
Total Debt Total Debt Growth | 2.22 | 2.22 | 2.58 | 5.79 | 12.52 | 6.46 |
Net Cash (Debt) Net Cash Growth | 4,134 | 4,004 | 3,729 | 3,529 | 3,520 | 2,770 |
Net Cash Growth | 1.80% | 7.39% | 5.67% | 0.25% | 27.09% | -1.86% |
Net Cash Per Share Net Cash Per Share Growth | 2.94 | 2.85 | 2.67 | 2.52 | 2.51 | 2.00 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 428.85 | 851.31 | 557.26 | 499.47 | 1,270 | 777.72 |
Capital Expenditures CapEx Growth | -47.84 | -74.59 | -285.72 | -186.55 | -221.09 | -499.78 |
Free Cash Flow Free Cash Flow Growth | 381.01 | 776.72 | 271.54 | 312.92 | 1,049 | 277.93 |
Free Cash Flow Growth | -61.71% | 186.04% | -13.22% | -70.17% | 277.39% | -58.25% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 36.63% | 36.58% | 37.62% | 36.66% | 35.81% | 37.78% |
Operating Margin | 15.56% | 16.54% | 16.47% | 18.76% | 17.06% | 18.69% |
Pretax Margin | 18.65% | 18.80% | 19.01% | 17.86% | 18.50% | 20.96% |
Profit Margin | 11.05% | 11.12% | 11.83% | 11.27% | 11.15% | 13.47% |
FCF Margin | 10.90% | 21.96% | 6.66% | 6.22% | 20.35% | 5.63% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.150 | 0.150 | 0.150 | 0.200 | 0.200 | 0.100 |
Dividend Per Share Growth | 0% | 0% | -25.00% | 0% | 100.00% | -50.00% |
Dividend Yield | 3.07% | 2.72% | 2.46% | 3.00% | 3.23% | 1.09% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 17.78 | 19.89 | 16.55 | 16.36 | 15.09 | 19.33 |
Forward PE | - | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 |
P/FCF Ratio | 17.74 | 10.07 | 29.37 | 29.66 | 8.26 | 46.26 |
PS Ratio | 1.93 | 2.21 | 1.96 | 1.84 | 1.68 | 2.61 |